VRCA
Verrica Pharmaceuticals Inc
4.10$
-1.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.63 | 0.43 | 0.82 | 1.11 | -0.38 | 0.05 | 0.36 | 1.34 | 1.51 | 0.48 | 0.24 | 0.28 | 1.42 | |
| 0.03 | 4.44 | 0.24 | 0.12 | 0.09 | 0.09 | 0.04 | 0.05 | 0.12 | 0.13 | 0.04 | 0.04 | 0.20 | |
| 0.60 | -4.01 | 0.58 | 1.00 | -0.47 | -0.04 | 0.32 | 1.29 | 1.39 | 0.35 | 0.19 | 0.23 | 1.22 | |
| 1.41 | 1.15 | 1.06 | 0.71 | 0.51 | 0.17 | 0.24 | 0.19 | 0.23 | 0.24 | 0.18 | 0.28 | 0.69 | |
| 4.35 | 3.67 | 3.19 | 3.32 | 3.20 | 0.92 | 0.90 | 0.93 | 0.99 | 0.80 | 0.47 | 0.49 | 1.80 | |
| 5.79 | 0.98 | 4.58 | 4.27 | 3.95 | 1.65 | 1.18 | 1.13 | 1.22 | 1.00 | 0.65 | 0.85 | 2.54 | |
| -5.19 | -5.00 | -4.00 | -3.27 | -4.42 | -1.69 | -0.86 | 0.16 | 0.17 | -0.65 | -0.46 | -0.61 | -1.32 | |
| 0.36 | 0.50 | 0.50 | 0.51 | 0.51 | 0.35 | 0.23 | 0.22 | 0.22 | 0.12 | 0.01 | 0.01 | 0.18 | |
| -5.38 | -5.31 | -4.37 | -3.70 | -4.88 | -2.41 | -1.03 | 0.02 | -0.03 | -0.76 | -0.45 | -0.62 | -1.46 | |
| -0.08 | 0.05 | 0.06 | – | -0.07 | -0.04 | – | – | – | – | – | – | – | |
| -5.38 | -5.31 | -4.37 | -3.70 | -4.88 | -2.41 | -1.03 | 0.02 | -0.03 | -0.76 | -0.45 | -0.62 | -1.46 | |
| -4.98 | -4.42 | -3.80 | -3.11 | -4.30 | -2.02 | -0.77 | 0.27 | 0.21 | -0.62 | -0.44 | -0.61 | -1.26 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.